Legal & General Group
PRVL

Legal & General Group’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Legal & General Group’s Portfolio PRVL Stock Details PRVL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$40K Sell
2020
Q3 		$18K Sell
2020
Q2 		$34K Buy
2020
Q1 		$26K Buy
2019
Q4 		$23K Buy
2019
Q3 		$15K Buy